Design Therapeutics, Inc. (DSGN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 57
-0.04
-0.3172%
$
853.79M Market Cap
- P/E Ratio
- Div Yield
468,200 Volume
-1.18 Eps
$ 12.61
Previous Close 
Want to track DSGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Design Therapeutics, Inc. (DSGN) Statistics
Valuation metrics
Market Cap 853.79M
Enterprise value 775.05M
Trailing P/E (ttm) -10.47
Forward P/E -
PEG ratio 0.54
Price/Sales (ttm) -
Price/Book (mrq) 3.54
Enterprise Value/Revenue -
Enterprise Value/EBITDA -11.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 396.59K
Average volume (90 days) 1.1M
Price summary
52-Week low 3.76
52-Week high 17.25
Beta -
50-Day moving average 12.29
200-Day moving average 11.23
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.3%
Return on equity -0.33%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 22.28%
Book value per share (mrq) 3.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
